TITLE

The Clinical Pharmacology of Cerebral Ischemia

AUTHOR(S)
SHARMA, PANKAJ; BROWN, MORRIS
PUB. DATE
October 1997
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Oct1997, Vol. 63 Issue 4, p558
SOURCE TYPE
Review
DOC. TYPE
Book Review
ABSTRACT
No abstract available.
ACCESSION #
66329330

 

Related Articles

  • Double-Blind Trial of Oral Papaverine in Chronic Cerebrovascular Ischemia. Shaw, Terry G.; Meyer, John Stirling // Angiology;Nov1978, Vol. 29 Issue 11, p839 

    A preliminary analysis of the effect of long-term therapy with oral papaverine has been made in 11 patients with chronic cerebral ischemia due to cerebral arteriosclerosis. The cases were classified as remote cerebral infarction (6 patients) or vertebrobasilar arterial insufficiency (5...

  • Letter of Apology. Graf, R. // Journal of Cerebral Blood Flow & Metabolism;Mar2005, Vol. 25 Issue 3, p291 

    The article presents a letter to the editor in response to the research "Cerebral ischemia and reperfusion: The pathophysiologic concept as a basis for clinical therapy."

  • Hypothermia and Cerebral Ischemia: Mechanisms and Clinical Applications. Zhao, Zonghang // Canadian Journal of Neurological Sciences;Feb2005, Vol. 32 Issue 1, p135 

    Reviews the book "Hypothermia and Cerebral Ischemia: Mechanisms and Clinical Applications," by Carolina M. Maier and Gary Steinberg.

  • Current Concepts of Neurocytoprotective Therapy. Gomazkov, O.; Afanasiev, V.; Rumyantseva, S.; Stupin, V.; Silina, E.; Sokhova, O. // Neuroscience & Behavioral Physiology;Mar2013, Vol. 43 Issue 3, p374 

    This review addressed the pharmacological effects and clinical efficacies of one of the 'oldest' neurocytoprotective agents - Cerebrolysin. Experimental data identifying the molecular mechanisms of action of this agent are described in detail, along with results from clinical trials...

  • A New Rat Model of Reversible Global Cerebral Ischemia. Shcherbak, N.; Galagudza, M.; Kuzmenkov, A.; Ovchinnikov, D.; Mitrofanova, L.; Barantsevich, E.; Shlyakhto, E. // Bulletin of Experimental Biology & Medicine;Mar2012, Vol. 152 Issue 5, p656 

    A new rat model of global cerebral ischemia-reperfusion was proposed via reversible occlusion of the major vessels originating from the aortic arch and supplying the brain. This technique can be used for the search and study of exogenous (pharmacological) and endogenous methods of brain...

  • MULTIPLE MICROINFARCTS: A FREQUENT MANIFESTATION OF CEREBRAL HUGHES/ANTIPHOSPHOLIPID SYNDROME(APS).  // Lupus;Jan2001 Supplement 1, Vol. 10, pS64 

    An abstract of the study "Multiple Microinfarcts: A Frequent Manifestation of Cerebral Hughes/Antiphospholipid Syndrome (APS)" is presented. It evaluates the prevalence of clinical cerebrovascular APS at the Lupus and Hematology clinics in 1999. The study reveals that a significant number of...

  • Нарушения церебральной микроциркуляци... ТРОФИМОВ, А. О.; КАЛЕНТЬЕВ, Г. В.; ВОЕННОВ, О. В.; ЮРЬЕВ, М. Ю.; ТРОФИМОВА, С. Ю.; АГАРКОВА, Д. И. // Regional Haemodynamics & Microcirculation;2015, Vol. 14 Issue 2, p4 

    The aim of the literature review was to present modern views on the possible mechanisms of the disturbances of capillary blood flow in severe brain injury (TBI). The critical analysis of the concept of secondary brain damage and possible mechanisms of the disturbances of cerebral...

  • Clinical characteristics of silent myocardial ischemia diagnosed with adenosine stress Tc-tetrofosmin myocardial scintigraphy in Japanese patients with acute cerebral infarction. Nomura, Tetsuya; Kusaba, Tetsuro; Kodama, Naotoshi; Terada, Kensuke; Urakabe, Yota; Nishikawa, Susumu; Keira, Natsuya; Matsubara, Hiroaki; Tatsumi, Tetsuya // Heart & Vessels;Jan2013, Vol. 28 Issue 1, p27 

    It is well known that silent myocardial ischemia (SMI) often complicates patients with cerebral infarction and that stroke patients often die of ischemic heart disease. Therefore, it is considered important to treat myocardial ischemia in stroke patients. This study investigated SMI complicating...

  • Pharmacologic Options for Prevention and Management of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage. Kiser, Tyree H. // Hospital Pharmacy;Sep2013 Supplement, Vol. 48, pS2 

    Background: Cerebral vasospasm and delayed cerebral ischemia continue to be major contributors to morbidity and mortality after aneurysmal subarachnoid hemorrhage (SAH).Purpose: The purpose of this review was to evaluate the pharmacotherapy interventions for the prevention and management of...

  • Prevention and treatment of brain ischaemia. Hinds, C.J. // British Medical Journal (Clinical Research Edition);9/21/1985, Vol. 291 Issue 6498, p758 

    Examines the prevention and treatment of brain ischemia. Definition of cerebral ischemia; Modification of ischemia by the residual flow; Assessment on the decrease of cerebral blood flow.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics